We are live on ! Find out more
P

Pitcairn Portfolio holdings

AUM $1.27B
1-Year Est. Return 23.64%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+23.64%
3 Year Est. Return
+111.21%
5 Year Est. Return
+126.49%
10 Year Est. Return
+390.83%
AUM
$866M
AUM Growth
-$39.8M
Cap. Flow
-$74.6M
Cap. Flow %
-8.62%
Top 10 Hldgs %
45.27%
Holding
519
New
33
Increased
93
Reduced
336
Closed
48

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$1.96M
2
MRK icon
Merck
MRK
+$1.75M
3
META icon
Meta Platforms (Facebook)
META
+$1.53M
4
WBD icon
Warner Bros
WBD
+$1.38M
5
FLS icon
Flowserve
FLS
+$1.36M

Top Sells

Rank Stock Value
1
IWV icon
iShares Russell 3000 ETF
IWV
+$6.74M
2
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
+$1.8M
3
FAST icon
Fastenal
FAST
+$1.77M
4
MOS icon
The Mosaic Company
MOS
+$1.61M
5
CERN
Cerner Corp
CERN
+$1.53M

Sector Composition

Rank Sector Weight
1 Consumer Staples 26.77%
2 Financials 9.04%
3 Healthcare 8.58%
4 Technology 7.65%
5 Industrials 6.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HOT
376
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$285K 0.03%
+3,520
New +$294K
FMC icon
377
FMC
FMC
$1.48B
$279K 0.03%
6,121
-113
-2% -$5.61K
WCC
378
WESCO International
WCC
$16.1B
$277K 0.03%
4,035
-79
-2% -$5.67K
STRZA
379
DELISTED
Starz - Series A
STRZA
$276K 0.03%
6,178
-237
-4% -$9.44K
MTD icon
380
Mettler-Toledo International
MTD
$26B
$272K 0.03%
795
-17
-2% -$5.6K
VRTX icon
381
Vertex Pharmaceuticals
VRTX
$120B
$272K 0.03%
2,205
-63
-3% -$7.94K
PXD
382
DELISTED
Pioneer Natural Resource Co.
PXD
$271K 0.03%
1,959
-11
-0.6% -$1.74K
QDEL icon
383
QuidelOrtho
QDEL
$1.14B
$270K 0.03%
11,771
-267
-2% -$6.22K
GM icon
384
General Motors
GM
$74.1B
$269K 0.03%
+8,064
New +$288K
MRO
385
DELISTED
Marathon Oil Corporation
MRO
$268K 0.03%
10,120
-119
-1% -$3.36K
NBL
386
DELISTED
Noble Energy, Inc.
NBL
$268K 0.03%
6,276
-157
-2% -$7.41K
LUMN icon
387
Lumen
LUMN
$6.9B
$267K 0.03%
9,089
-5,120
-36% -$174K
MTN icon
388
Vail Resorts
MTN
$5.16B
$267K 0.03%
2,441
-126
-5% -$13.2K
IMO icon
389
Imperial Oil
IMO
$60.8B
$265K 0.03%
6,879
-291
-4% -$12K
APC
390
DELISTED
Anadarko Petroleum
APC
$265K 0.03%
3,395
+218
+7% +$18.9K
CAG icon
391
Conagra Brands
CAG
$7.1B
$263K 0.03%
7,728
-26
-0.3% -$781
NOV icon
392
NOV
NOV
$7.3B
$263K 0.03%
5,435
-174
-3% -$8.94K
UDR icon
393
UDR
UDR
$12.8B
$260K 0.03%
8,131
-229
-3% -$7.52K
MANH icon
394
Manhattan Associates
MANH
$8.82B
$258K 0.03%
+4,329
New +$240K
SJM icon
395
J.M. Smucker
SJM
$12.6B
$258K 0.03%
2,385
-57
-2% -$6.6K
SGY
396
DELISTED
Stone Energy
SGY
$258K 0.03%
362
-17
-4% -$14.4K
GIS icon
397
General Mills
GIS
$19.7B
$256K 0.03%
4,599
-35
-0.8% -$1.96K
LGND icon
398
Ligand Pharmaceuticals
LGND
$6.1B
$256K 0.03%
4,059
-739
-15% -$40.3K
THC icon
399
Tenet Healthcare
THC
$16.8B
$255K 0.03%
4,393
-211
-5% -$10.8K
ABG icon
400
Asbury Automotive
ABG
$4.16B
$251K 0.03%
2,769
-59
-2% -$5.12K
14 15
16
17 18

Similar funds

SFI
SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return
WCWM
Willow Creek Wealth Management Sebastopol, California $1.21B AUM 7.45% 1-Year Est. Return
BA
Bristlecone Advisors Bellevue, Washington $1.2B AUM 19.79% 1-Year Est. Return
SAM
Scion Asset Management Saratoga, California $1.38B AUM 43.96% 1-Year Est. Return
4CM
400 Capital Management New York $1.4B AUM
SIMG
Sonora Investment Management Group Tucson, Arizona $1.41B AUM 20.58% 1-Year Est. Return
HT
HAP Trading New York $1.42B AUM 41.92% 1-Year Est. Return
BCM
Bares Capital Management Austin, Texas $1.08B AUM 38.13% 1-Year Est. Return

Pitcairn's Q2 2015 Portfolio in Review

As of Q2 2015, Pitcairn held 519 positions worth $866M, down 4.4% from $905M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Pitcairn withdrew a net $74.6M in Q2 2015, closing 48 positions and reducing 336 holdings. Its most notable exit was CATAMARAN CORP COM STK (CDA), an estimated $1.8M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 27% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Pitcairn opened a new position in Centene worth $1.35M.

  • Pitcairn's largest Q2 2015 buy was Centene: 33,702 shares worth $1.35M.
  • Pitcairn added most to Eli Lilly in Q2 2015, an estimated $1.96M increase.
  • Pitcairn's biggest Q2 2015 reduction was iShares Russell 3000 ETF, cutting an estimated $6.74M.
  • Pitcairn fully exited CATAMARAN CORP COM STK (CDA) in Q2 2015, selling an estimated $1.8M.
  • Pitcairn's ten largest holdings make up 45% of its $866M portfolio in Q2 2015.
  • Pitcairn opened 33 new positions and closed 48 in Q2 2015.
  • Pitcairn's portfolio value fell 4.4% quarter-over-quarter to $866M.

Based on Pitcairn's 13F filing for Q2 2015, filed 6 Aug 2015.